The 11th International Conference on Rare Diseases and Orphan Drugs (ICORD), South Africa, included the Africa-Rare initiative launch and facilitated multi-stakeholder engagement in the challenges facing, and opportunities for, Africans living with rare diseases. The following ICORD Global Call to Action, developed in collaboration with the International Rare Diseases Research Consortium, synthesizes the outcomes of the deliberations and emphasizes the international collaborative efforts required to address the global effects of rare diseases on public health.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
WA Rare Diseases Strategic Framework 2015–2018 (Government of Western Australia Department of Health, 2018); http://ww2.health.wa.gov.au/Reports-and-publications/WA-Rare-Diseases-Strategic-Framework-2015-2018
Valdez, R., Ouyang, L. & Bolen, J. Prev. Chronic Dis. 13, 150491 (2016).
Rare Diseases: Understanding This Public Health Priority (European Organisation for Rare Diseases, 2005); https://www.eurordis.org/IMG/pdf/princeps_document-EN.pdf
2013 Report on the State of the Art of Rare Disease Activities in Europe (European Union Committee of Experts on Rare Diseases, 2013); http://www.eucerd.eu/upload/file/Reports/2013ReportStateofArtRDActivities.pdf?bcsi_scan_313cddce030931be=0&bcsi_scan_filename=2013ReportStateofArtRDActivities.pdf
Schieppati, A., Henter, J. I., Daina, E. & Aperia, A. Lancet 371, 2039–2041 (2008).
Ogunrin, O., Taiwo, F. & Frith, L. J. Empir. Res. Hum. Res. Ethics 14, 78–87 (2019).
Pepper, M.S. et al. S. Afr. J. Sci. https://doi.org/10.17159/sajs.2018/a0302 (2018).
Dawkins, H. J. S. et al. Clin. Transl. Sci. 11, 11–20 (2018).
Taruscio, D., Floridia, G., Salvatore, M., Groft, S. C. & Gahl, W. A. Adv. Exp. Med. Biol. 1031, 25–38 (2017).
Taruscio, D. et al. Mol. Genet. Metab. 116, 223–225 (2015).
Manolio, T. A. et al. Nature 461, 747–753 (2009).
Gravel, S. et al. Proc. Natl Acad. Sci. USA 108, 11983–11988 (2011).
Bustamante, C. D., Burchard, E. G. & De la Vega, F. M. Nature 475, 163–165 (2011).
Muenke, M., Adeyemo, A. & Kruszka, P. Genet. Med. 18, 1085–1087 (2016).
Bilkey, G. A. et al. Front. Public Health 7, 42 (2019).
Malherbe, H. L., Christianson, A. L., Woods, D. & Aldous, C. J. Community Genet. 8, 65–73 (2017).
Taruscio, D. et al. Public Health Genomics 17, 115–123 (2014).
Taruscio, D. et al. Adv. Exp. Med. Biol. 1031, 301–322 (2017).
Lebese, V., Aldous, C. & Malherbe, H. L. S. Afr. Med. J. 106, 992–995 (2016).
Rajmil, L., Perestelo-Pérez, L. & Herdman, M. Adv. Exp. Med. Biol. 686, 251–272 (2010).
Taruscio, D. et al. Public Health Genomics 18, 184–191 (2015).
Martins, C., Godycki-Cwirko, M., Heleno, B. & Brodersen, J. Eur. J. Gen. Pract. 24, 106–111 (2018).
Nowak, K. J., Bauskis, A., Dawkins, H. J. & Baynam, G. Eur. J. Hum. Genet. 26, 616–617 (2018).
Parker, M. & Kwiatkowski, D. P. Genome Biol. 17, 44 (2016).
Acknowledgements
We thank F. S. Alkuraya for valuable insights during the development of this manuscript and J. Groft for providing the protea flower pictures (Supplementary Note). We also thank the 11th International Conference on Rare Diseases and Orphan Drugs, without which the development of this manuscript would not have been possible.
G.S.B. is supported by the Angela Wright Bennett Foundation, McCusker Charitable Foundation and Roy Hill Community Foundation. J.K. is supported by H3ABioNet, which is funded by NIH Common Fund Award/NHGRI grant U41HG006941. J.K.V.R. is supported by IDFEC, the International Development Fund for Economy and Culture. C.N. is supported by MRC Fellowship MR/M014568/1.
Author information
Authors and Affiliations
Contributions
G.S.B., S.G., F.H.v.d.W., S.D.G., K.d.P., E.S., M. Selebasto, B.G., T.S., D.J., V.A.L., B.C.V., B.W., B.D., C.P.A., J.K., J.F., P.K., J.C., D.G., A.L., M. Stojiljkovic, A.N., E.J.A.R., D.T., D.W.-R., C.D.M.v.K. and M.P. conceived the paper concept. G.S.B., S.G., F.H.v.d.W., S.D.G., K.d.P., E.S., V.A.L., B.C.V., B.W., B.D., C.P.A., J.K., J.F., P.K., J.C., D.G., A.L., M. Stojiljkovic, A.N., E.J.A.R., D.T., D.W.-R., C.D.M.v.K., M.P., E.P.C., S.E., S. Bowdin, K.K., M.G., Z.S., R.M.-S., D.R.A., R.D.P., F.Z., N.P., M.M. and H.C. drafted the manuscript. G.S.B., S.G., F.H.v.d.W., S.D.G., C.P.A., J.K., D.G., A.L., M. Stojiljkovic, A.N., D.T., C.D.M.v.K., M.P., E.P.C., S.E., S. Bowdin, K.K., M.G., Z.S., R.M.-S., D.R.A., R.D.P., F.Z., N.P., M.M., H.C., M. Selebasto, B.G., T.S., D.J., K.N., G.A.B., J.K.V.R., S. Beltran, C.N., W.A.G., S. Broley, M. Schoonen, and K.M.B. edited the manuscript. All authors reviewed and approved the final manuscript version for submission.
Corresponding author
Ethics declarations
Competing interests
The authors declare the existence of a non-financial competing interest, acknowledging the involvement of select authors in the International Conference on Rare Diseases and Orphan Drugs, the International Rare Diseases Research Consortium (IRDiRC), the Undiagnosed Diseases Network International, Rare Diseases International and Rare Diseases South Africa.
Supplementary information
Supplementary Information
Supplementary Note
Rights and permissions
About this article
Cite this article
Baynam, G.S., Groft, S., van der Westhuizen, F.H. et al. A call for global action for rare diseases in Africa. Nat Genet 52, 21–26 (2020). https://doi.org/10.1038/s41588-019-0552-2
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41588-019-0552-2